Company Search:
Advanced Search
Sponsored Links
Corestem Inc Company Snapshot
Corestem Inc operates in the Biological products exc. diagnostic sector. In addition to historical fundamental analyses, the complete report available to purchase compares Corestem Inc with three other companies in this sector in KOREA (SOUTH) : ISU Abxis Company Limited (2019 sales of 21.02 billion Korean Won [US$17.64 million] of which 100% was Antibody Medicine), Choong Ang Vaccine Laboratory (32.90 billion Korean Won [US$27.61 million] of which 100% was Animal Health Product), and Alteogen Inc (29.23 billion Korean Won [US$24.52 million] of which 100% was Biotechnology Research&Development).

Sales Analysis. Corestem Inc reported sales of 24.28 billion Korean Won (US$20.37 million) for the year ending December of 2019. This represents an increase of 8.8% versus 2018, when the company's sales were 22.32 billion Korean Won . This was the third consecutive year of growth at Corestem Inc. Sales of Cell Therapeutic Pharmaceuticals saw an increase that was more than double the company's growth rate: sales were up 18.2% in 2019, from 2.87 billion Korean Won to 3.39 billion Korean Won .
Company ReportsSubscriptions
Looking For More?
Purchace an In-Depth Report
Corestem Inc
  Stock Performance Chart for Corestem Inc
  Stock Data: Recent Stock Performance:
  Current Price (7/3/2020): 16,800
(Figures in Korean Won )
1 Week -5.6%   13 Weeks -7.9%  
4 Weeks 56.3%   52 Weeks 67.2%  
Corestem Inc Key Data:
  Ticker: 166480 Country: Korea (South)
  Exchanges: SEO Major Industry: Pharmaceuticals & Biotechnology
    Sub Industry: Biological Products Exc. Diagnostic
  2019 Sales 24,284,457,085
(Year Ending Jan 2020).
Employees: 40
  Currency: Korean Won Market Cap: 264,052,992,000
  Fiscal Yr Ends: December Shares Outstanding: 15,717,440
  Share Type: Common Closely Held Shares: 4,223,400
Feedback | Terms and Conditions | Privacy Policy | Site Index
CorporateInformation® website and selected data Copyright © 2000 - by The Winthrop Corporation. All Rights Reserved. Except for quotations by established news media, no pages on this site may be reproduced, stored in a retrieval system, or transmitted for commercial purposes, in any form or by any means, electronic, mechanical, photocopying, recording, or otherwise without prior written permission. Information is believed reliable, but accuracy, completeness and opinions are not guaranteed.